Efficacy of the Telemedical Lifestyle intervention Program TeLiPro in Advanced Stages of Type 2 Diabetes: A Randomized Controlled Trial.

Source: Kempf, K., et al. 2017 - Pubmed ID: 28500214

Setting: Germany, Attending physician

Study design:



Follow up: 52 weeks

Patient group:

Sample size:

Total: 202 ( 133)

IG: 102 (77)

CG: 100 (56)


Inclusion criteria:

  • Diabetes type 2
  • Overweight or obese
Type of technology:

Home monitoring

  • Weighing scale
  • Step counter
  • Blood glucose meter.


Webpage (TeLiPro device)

  • Data upload
  • Data transfer


Phone call

  • Information
  • Guidance

Intervention: Patients monitor and transfer their clinical data via TeLiPro device. Diabetes coaches calls patient weekly for discussion of measured data and for diabetes relevant information


Duration: 12 weeks
Add on: NA


Control group: Routine health care visits

Clinical effect/ Patient safety:

Clinical effect:

  • HbA1c ↓
  • Body weight ↓
  • BMI ↓
  • Bp ↓
  • Physical health ↑
  • Cognitive control ↑
  • Medication demands ↓

Patient safety: No adverse events were reported

Patient experiences/ Staff experiences:

Patient experiences: NA

Staff experiences:

Costs and organization:



  • Glucometer
  • Weight
  • Step counter


Staff resources

  • Weekly care calls


Health care utilization: NA

Scroll to Top


“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)